Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Response Evaluation Criteria in Cancer of the Liver

Known as: RECICL 
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). (Kudo M, Kubo… Expand
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)
Response Evaluation Criteria in Solid Tumors (RECIST) is inappropriate to assess the direct effects of treatment on… Expand
Is this relevant?
2018
2018
Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in…
AIM To evaluate the potential value of texture analysis (TA) based on contrast-enhanced magnetic resonance imaging (MRI) for… Expand
Is this relevant?
2016
2016
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)
The Response Evaluation Criteria in Solid Tumors (RECIST) is inappropriate to assess the direct effects of treatment on… Expand
Is this relevant?
2016
2016
Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short‐term results
The goal of the study was to evaluate the efficacy and safety of balloon‐occluded transarterial chemoembolization (B‐TACE) of… Expand
Is this relevant?
2015
2015
Response evaluation criteria in cancer of the liver (RECICL 2015 revised version)
 
Is this relevant?
2014
2014
Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
BackgroundTo test the hypothesis that use of the response evaluation criteria in cancer of the liver (RECICL), an improved… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2014
2014
Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.
AIM We aimed to retrospectively examine the tolerability and efficacy of transarterial chemoembolization (TACE) in patients with… Expand
  • figure 1
  • table II
  • table I
  • table III
  • figure 2
Is this relevant?
2013
2013
Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?
PURPOSE In order to detect an early response to anti-angiogenic therapy, this study aims at analyzing specific effects of a… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)
The World Health Organization (WHO) criteria and Response Evaluation Criteria in Solid Tumors (RECIST) are inappropriate to… Expand
Is this relevant?
2010
2010
Response Evaluation Criteria in Cancer of the Liver (RECICL)
 
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE